TY - JOUR
T1 - Virus‐specific serum IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique
AU - Porath, Avi
AU - Hanuka, Negba
AU - Keynan, Arie
AU - Sarov, Israel
PY - 1987/1/1
Y1 - 1987/1/1
N2 - The immune response to individual human cytomegalovirus (CMV) structural polypeptides was studied in paired sera from 15 adult CMV mononucleosis (CMVMN) patients and healthy controls by immunoblotting technique (IB). IgM and IgG antibodies to at least 11 structural polypeptides with molecular weights of 28K, 49K. 55K, 57K. &‐7OK, 82K, 87K, IIOK, 150K. 205K, and 235K were detected in the patients sera in the serum sample obtained in the acute phase of the disease. IgA antibodies to polypeptides with molecular weights of 66‐70K. 82K. 11OK, and 150K were also detected in these sera. In healthy seropositive adults, IgG antibodies with the same molecular weight polypeptides, excluding the 205K and 235K polypeptides, were detected as in convalescent CMV‐MN patients. A prominent reactivity of IgM and IgA antibodies to the 66‐70K and ISOK polypeptides was noted in the acute sera from all the CMV‐MN patients examined, but not in a number of late convalescent sera. The potential implications of these findings in the development of specific serological tests are discussed.
AB - The immune response to individual human cytomegalovirus (CMV) structural polypeptides was studied in paired sera from 15 adult CMV mononucleosis (CMVMN) patients and healthy controls by immunoblotting technique (IB). IgM and IgG antibodies to at least 11 structural polypeptides with molecular weights of 28K, 49K. 55K, 57K. &‐7OK, 82K, 87K, IIOK, 150K. 205K, and 235K were detected in the patients sera in the serum sample obtained in the acute phase of the disease. IgA antibodies to polypeptides with molecular weights of 66‐70K. 82K. 11OK, and 150K were also detected in these sera. In healthy seropositive adults, IgG antibodies with the same molecular weight polypeptides, excluding the 205K and 235K polypeptides, were detected as in convalescent CMV‐MN patients. A prominent reactivity of IgM and IgA antibodies to the 66‐70K and ISOK polypeptides was noted in the acute sera from all the CMV‐MN patients examined, but not in a number of late convalescent sera. The potential implications of these findings in the development of specific serological tests are discussed.
KW - CMV
KW - immune response
KW - serodiagnosis
KW - viral polypeptide
UR - http://www.scopus.com/inward/record.url?scp=0023260060&partnerID=8YFLogxK
U2 - 10.1002/jmv.1890220305
DO - 10.1002/jmv.1890220305
M3 - Article
AN - SCOPUS:0023260060
SN - 0146-6615
VL - 22
SP - 223
EP - 230
JO - Journal of Medical Virology
JF - Journal of Medical Virology
IS - 3
ER -